Legal & General Group
FATE icon

Legal & General Group’s Fate Therapeutics FATE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$11.7K Buy
10,398
+1,754
+20% +$1.97K ﹤0.01% 3228
2025
Q1
$6.83K Hold
8,644
﹤0.01% 3239
2024
Q4
$14.3K Sell
8,644
-80,686
-90% -$133K ﹤0.01% 3155
2024
Q3
$313K Hold
89,330
﹤0.01% 2606
2024
Q2
$293K Buy
89,330
+76,929
+620% +$252K ﹤0.01% 2607
2024
Q1
$91K Sell
12,401
-5,229
-30% -$38.4K ﹤0.01% 2741
2023
Q4
$65.9K Sell
17,630
-36,901
-68% -$138K ﹤0.01% 2780
2023
Q3
$116K Sell
54,531
-25,781
-32% -$54.7K ﹤0.01% 2812
2023
Q2
$382K Sell
80,312
-254,098
-76% -$1.21M ﹤0.01% 2547
2023
Q1
$1.91M Buy
334,410
+214,616
+179% +$1.22M ﹤0.01% 1899
2022
Q4
$1.21M Buy
119,794
+12,132
+11% +$122K ﹤0.01% 2093
2022
Q3
$2.41M Sell
107,662
-14,155
-12% -$317K ﹤0.01% 1767
2022
Q2
$3.02M Buy
121,817
+15,477
+15% +$384K ﹤0.01% 1674
2022
Q1
$4.12M Buy
106,340
+4,919
+5% +$191K ﹤0.01% 1627
2021
Q4
$5.93M Buy
101,421
+6,997
+7% +$409K ﹤0.01% 1479
2021
Q3
$5.6M Buy
94,424
+37,460
+66% +$2.22M ﹤0.01% 1488
2021
Q2
$4.94M Buy
56,964
+5,426
+11% +$471K ﹤0.01% 1536
2021
Q1
$4.25M Sell
51,538
-892
-2% -$73.5K ﹤0.01% 1642
2020
Q4
$4.77M Buy
52,430
+5,052
+11% +$459K ﹤0.01% 1482
2020
Q3
$1.89M Buy
47,378
+24,721
+109% +$988K ﹤0.01% 1782
2020
Q2
$778K Buy
22,657
+581
+3% +$20K ﹤0.01% 2056
2020
Q1
$491K Sell
22,076
-8,897
-29% -$198K ﹤0.01% 2072
2019
Q4
$606K Buy
30,973
+3,741
+14% +$73.2K ﹤0.01% 2189
2019
Q3
$423K Buy
27,232
+16,500
+154% +$256K ﹤0.01% 2190
2019
Q2
$218K Sell
10,732
-1,000
-9% -$20.3K ﹤0.01% 2328
2019
Q1
$206K Buy
11,732
+356
+3% +$6.25K ﹤0.01% 2323
2018
Q4
$146K Buy
11,376
+3,719
+49% +$47.7K ﹤0.01% 2374
2018
Q3
$125K Hold
7,657
﹤0.01% 2452
2018
Q2
$87K Sell
7,657
-886
-10% -$10.1K ﹤0.01% 2540
2018
Q1
$83K Buy
8,543
+758
+10% +$7.36K ﹤0.01% 2531
2017
Q4
$48K Buy
7,785
+2,158
+38% +$13.3K ﹤0.01% 2876
2017
Q3
$22K Hold
5,627
﹤0.01% 3147
2017
Q2
$18K Buy
+5,627
New +$18K ﹤0.01% 3218